Optimum duration of extended adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: protocol for a network meta-analysis of randomised controlled trials

INTRODUCTION: The type of extended adjuvant endocrine therapy is not clear, nor is the optimum duration of extended adjuvant endocrine therapy for patients with early breast cancer. Our study aims to satisfy the requirements for systematically identifying and synthesising the available evidence on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiancheng, Ye, Daoli, Xudong, Zhao, Wang, Qingfeng, Gou, Hongfeng, Luo, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124296/
https://www.ncbi.nlm.nih.gov/pubmed/37080619
http://dx.doi.org/10.1136/bmjopen-2022-070972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124296/
https://www.ncbi.nlm.nih.gov/pubmed/37080619
http://dx.doi.org/10.1136/bmjopen-2022-070972

Ejemplares similares